TransMedics Group, Inc. Quarterly Cost of Revenue in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
TransMedics Group, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2018 to Q3 2024.
  • TransMedics Group, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $47.9M, a 86% increase year-over-year.
  • TransMedics Group, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $163M, a 151% increase year-over-year.
  • TransMedics Group, Inc. annual Cost of Revenue for 2023 was $87.5M, a 211% increase from 2022.
  • TransMedics Group, Inc. annual Cost of Revenue for 2022 was $28.2M, a 210% increase from 2021.
  • TransMedics Group, Inc. annual Cost of Revenue for 2021 was $9.1M, a 1.1% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $163M $47.9M +$22.1M +86% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $141M $45M +$29.3M +186% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $112M $36.9M +$24.1M +188% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $87.5M $33.3M +$22.6M +212% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $65M $25.8M +$18.2M +240% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $46.8M $15.7M +$9.55M +155% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $37.2M $12.8M +$9.01M +239% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $28.2M $10.7M +$7.99M +298% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $20.2M $7.57M +$5.97M +374% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $14.2M $6.17M +$3.59M +139% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $10.6M $3.78M +$1.53M +68.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $9.1M $2.68M -$117K -4.18% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $9.22M $1.6M -$456K -22.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $9.68M $2.58M +$1.1M +74.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $8.58M $2.24M -$428K -16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $9M $2.8M +$483K +20.9% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 $8.52M $2.05M -$936K -31.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $9.46M $1.48M -$851K -36.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $10.3M $2.67M +$567K +27% Dec 29, 2019 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $9.74M $2.32M +$271K +13.3% Sep 29, 2019 Dec 28, 2019 10-K 2021-03-11
Q3 2019 $9.47M $2.99M +$1.08M +56.7% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-06
Q2 2019 $8.39M $2.33M +$597K +34.4% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-10
Q1 2019 $7.79M $2.1M +$508K +31.9% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-06
Q4 2018 $7.28M $2.05M Sep 30, 2018 Dec 29, 2018 10-K 2020-03-17
Q3 2018 $1.91M Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-08
Q2 2018 $1.74M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.6M Dec 31, 2017 Mar 31, 2018 10-Q 2019-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.